Correction to Impact of U.S. Support for Patent Waiver on Vaccine Makers Article
Moderna Inc. agreed to provide its Covid-19 vaccine to the Covax
initiative at Moderna's lowest-tiered price. "U.S. Support for
Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Short
Term" at 3:04 p.m. ET, incorrectly said Moderna agreed to donate
(END) Dow Jones Newswires
May 07, 2021 19:40 ET (23:40 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.